Radnostix, Inc. (INIS)
OTCMKTS · Delayed Price · Currency is USD
0.0600
0.00 (0.00%)
Aug 27, 2026, 2:46 PM EST
Radnostix Revenue
Radnostix had revenue of $2.67M in the quarter ending June 30, 2026, a decrease of -26.91%. This brings the company's revenue in the last twelve months to $11.23M, down -23.73% year-over-year. In the year 2025, Radnostix had annual revenue of $13.07M, down -5.97%.
Revenue (ttm)
11.23M
Revenue Growth
-23.73%
P/S Ratio
2.80
Revenue / Employee
249.49K
Employees
45
Market Cap
31.48M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 13.07M | -829.42K | -5.97% |
| Dec 31, 2024 | 13.90M | 1.63M | 13.31% |
| Dec 31, 2023 | 12.27M | 1.09M | 9.71% |
| Dec 31, 2022 | 11.18M | 1.52M | 15.73% |
| Dec 31, 2021 | 9.66M | 297.05K | 3.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Eagle Pharmaceuticals | 257.55M |
| MariMed | 163.82M |
| Earth Science Tech | 35.96M |
| CordovaCann | 9.83M |
| Healthy Extracts | 6.29M |
| Bio Essence | 2.91M |
| Panacea Life Sciences Holdings | 2.76M |
| Growth Stalk Holdings | 583.34K |
Radnostix News
- 15 days ago - Radnostix, Inc. Reports FY2026 2nd Quarter and Six Months Results - Completes Execution of FDA 483 & Recall Actions, Restores Capsule Inventory, Completes Lucerno Dynamics Asset Acquisition - PRNewsWire
- 2 months ago - Radnostix Acquires Lucerno Dynamics Assets Expanding Radiopharma Medical Device Portfolio - PRNewsWire
- 3 months ago - Radnostix, Inc. Reports FY2026 Q1 Results - Revenue Declines 27% Primarily Due to Voluntary Product Recalls, Isotope Supply Disruptions, and Planned Operational Shutdown - PRNewsWire
- 5 months ago - Radnostix, Inc. Reports FY2025 Results - Second-Highest Annual Revenue in Company History; Delivers Strong Growth in Calibration & Reference Products and Advances Key Product Launches in 2025 - PRNewsWire
- 5 months ago - Radnostix announces mutual termination of APA related to DUF6 assets - TheFly
- 8 months ago - International Isotopes announces name change to Radnostix - TheFly
- 8 months ago - International Isotopes Inc. Announces Company Name Change to Radnostix, Inc. - PRNewsWire
- 10 months ago - INTERNATIONAL ISOTOPES INC. ANNOUNCES FISCAL RESULTS FOR THE THIRD QUARTER AND NINE MONTHS ENDED SEPTEMBER 30, 2025 - PRNewsWire